Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes

Back

HFA Premium Access

Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes

Session: From bedside to bench and back

Topic: Cardiomyopathies

Speaker: Mr F. Deiman (Groningen, NL)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Mr Frederik Ernst Deiman

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

6 more presentations in this session

Proteomic clusters of patients with new onset heart failure; more inflammation and worse prognosis in cluster with preserved ejection fraction - the PREFERS Study

Speaker: Assistant Professor C. Hage (Stockholm, SE)

Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size

Speaker: Mr M. Sikking (Maastricht, NL)

Identification of risk and protective factors in titin cardiomyopathy

Speaker: Miss S. Stroeks (Maastricht, NL)

Defect in PKA-mediated proteasome activation is a key pathogenic factor for cardiac proteinopathy

Speaker: Professor X. Wang (Vermillion, US)

ATPase inhibitory factor 1 (ATPIF-1) preserves cardiac function during ageing

Speaker: Mr P. Sanchez (Groningen, NL)

Access the full session

From bedside to bench and back

Speakers: Mr F. Deiman, Assistant Professor C. Hage, Mr M. Sikking, Miss S. Stroeks, Professor X. Wang...

Access

Video

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources